RealNose.ai

RealNose.ai

United StatesUnited States
•Seed•Founded 2023•Updated 3d ago
HealthtechDefenseBio Tech/Life SciencesDeep TechB2BB2G1-5 employees
Exited FounderExited Founder

About

RealNose.ai is building a machine-olfaction platform that digitizes scent. Its chips use stabilized mammalian olfactory receptors that respond to airborne molecules, and its reader converts the response pattern into an electronic signal that software learns to match to defined targets. The company is initially targeting prostate cancer detection from urine and defense chemical sensing.

Team

Nikolas

Nikolas

CEO

Andreas

Andreas

CSO

Products

RealNose Scent Sensing Platform

A machine-olfaction platform that digitizes scent using stabilized mammalian olfactory receptors on a chip. The reader records the response pattern across receptors, and software learns which patterns match a defined target, enabling field-ready chemical sensing for defense and other applications.

Click to read more

RealNose Prostate Cancer Urine Test

An in-development urine-based assay for prostate cancer detection that aims to help clinicians decide on biopsies after elevated PSA results. It is intended to be run as a single-lab test; clinical performance still requires prospective validation.

Click to read more